FAA opens door to mental health treatment for pilots, controllers
H.R. 2591 — Mental Health in Aviation Act of 2025 · Filed by Sean Casten (D-IL) · 43 cosponsors · Introduced Apr 2, 2025 · Passed chamber
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill requires the FAA to update its medical certification rules within 2 years to encourage pilots and air traffic controllers to seek mental health treatment and disclose mental health conditions without automatic disqualification. It directs the FAA to review and approve additional psychiatric medications as safe for airmen, improve training for aviation medical examiners, and allocate $13.74 million annually (2026–2028) to hire more medical examiners and clear backlogs, plus $1.5 million annually for a public campaign to destigmatize mental health care in aviation.
Why we flagged it
The bill's core mechanism is regulatory modernization to encourage mental health disclosure among aviation personnel while maintaining safety standards. It is fundamentally a public-health and occupational-safety measure, not a deregulation or industry carve-out.
What the text implies
- Pilots and air traffic controllers may face reduced privacy if mental health disclosures become routine; the bill does not establish confidentiality protections beyond existing medical privacy law, potentially creating a chilling effect if disclosure records are discoverable in litigation or employment disputes.
- The $13.74M annual appropriation for additional aviation medical examiners may not be sufficient to clear existing backlogs if demand for mental health special issuances surges; implementation delays could frustrate the bill's destigmatization goal.
The full analysis lists 4 implications of this text.
Who stands to gain
Aviation medical examiners (expanded hiring and delegated authority); Psychiatric and mental health service providers (increased demand from destigmatization campaign); Pharmaceutical companies with psychiatric medications approved for aviation use (expanded market amo